Teva shares prove resilient to blow for experimental MS drug

JERUSALEM, Jan 26 (Reuters) - Investors in Israel's Teva Pharmaceutical Industries largely shrugged off a negative opinion from the European Medicines Agency (EMA) on multiple sclerosis (MS) drug...

from Reuters: Hot Stocks http://ift.tt/1n0OD6j